Somu Subramaniam

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

K2M, Inc. manufactures and markets medical devices. It offers deformity correction systems, spinal stabilization systems, lateral access systems, minimally invasive systems, and, constrained and translational cervical plates. The company was founded by John Philip Kostuik and Eric Major in January 2004 and is headquartered in Leesburg, VA.

Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ.

BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.

Achronix Semiconductor Corp. offers high-density and high-performance application-targeted field programmable gate arrays. Its products include Speedster22i HD, Speedster22i HP, ACE, Boards, Documentation and Video Demos. The firm also offers the Achronix CAD environment (ACE), an easy-to-use, mature, robust design-tool suite for its customers and ACE includes integrated support for industry-standard synthesis tools Synplify Pro and Precision Synthesis. The company was founded by John Lofton Holt, Rajit Manohar, Virantha N. Ekanayake, and Clinton W. Kelly VI in 2004 and is headquartered in Santa Clara, CA.

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

Vorago Technologies, Inc. operates as a fabless semiconductor company. Its products include RH 8Mb Dual Port SRAM, HT 8Mb Dual Port SRAM, RH 16Mb Asynchronous SRAM and RH 18Mb Sync Burst SRAM. The firm provides radiation and temperature-hardened IC components for the Hi-Reliability marketplace. The company designs and develops high density SRAMs and logic ICs using its patented HardSIL technologies The company was founded by Wesley Harold Morris in 2004 and is headquartered in Austin, TX.

Svelte Medical Systems, Inc. develops balloon expandable stents. It offers balloon control band technologies, hybrid stent design and integrated delivery systems. The firm has locations in Brussels, New Providence and Sao Paulo. The company was founded by Robert E. Fischell, David R. Fischell and Tim A. Fischell in 2007 and is headquartered in New Providence, NJ.

Lightwire, Inc. manufactures optical networking equipment. Its products include optical transceiver modules and ethernet optoelectronic interconnects. The company was founded by Kalpendu Shastri in 2002 and is headquartered in Allentown, PA.

Dali Systems Co. Ltd. engages in manufactures antenna systems. The company is headquartered in Grand Cayman, Cayman Islands.

Ferric, Inc. develops integrated circuits and integrated inductors in CMOS technology for use in on-chip voltage regulators. Its products include chips and circuit IP, power management IC, packaged integrated voltage regulators and stack integrated voltage regulators. The firm offers power converters utilizing inductors. Its technology can be applies across a broad spectrum of power electronics ranging from full scale servers to the chip level. The company was founded in 2011 by Noah Sturcken, Maurizio Arienzo and Kenneth Shepard and is headquartered in New York, NY.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Vascular Therapeutics, Inc. develops glycol therapeutics for cardiovascular diseases. The firm also discovers and develops therapeutic agents to prevent & treat life-threatening blood clotting disorders. It serves cardiovascular diseases such as acute myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. The company was founded in July, 1994 and is headquartered in Mountain View, CA.

TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA.

Brightvolt Solid State Batteries provides embedded power solutions. It also develops custom solid state thin film batteries and power solutions for client’s IoT devices; flexion solid state thin film lithium polymer batteries; and thin micro electronics. The company was founded by Robert Singleton and Craig Nelson in 2001 and is headquartered in Redmond, WA.

New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Dali Wireless, Inc. provides wireless coverage and capacity solutions. Its products include cellular, public safety, and software. It offers all digital distributed antenna system, dynamic capacity allocation, coverage extension, and radio access network virtualization solutions. The company was founded by Leo K. Wong, Albert S. Lee and Dali Yang in 2006 and is headquartered Menlo Park, CA.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

MagSil Corp. develops magnetic random access memory technology. Its patented innovative magnetic recording cell architecture combines magnetic technology with mainstream semiconductor manufacturing processes, enabling the development of a disruptive technology for stand-alone and embedded magnetic random access memory products. The company’s technology will be ideal for integrated device manufacturers, pure-play semiconductor foundries and OEMs to embed or use stand-alone magnetic random access memory devices in a system. MagSil was founded by Krishnakumar Mani in 2004 and is headquartered in Santa Clara, CA.

Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA.

Vaultive, Inc. provides cloud data encryption solutions. It enables customers to encrypt data-at-rest and data-in-use within the hosted Microsoft exchange environment, while enterprise information technology retains complete control of the encryption keys. The firm’s hosted exchange does not interfere with standard email security features such as malware and antivirus protection. The company was founded by Ben Matzkel and Maayan Tal in 2009 and is headquartered in Boston, MA.

ario pharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of respiratory indications. The company was founded by John Ford and Patrick M. Round in 2010 and is headquartered in Great Shelford, the United Kingdom.

Tigerconnect, Inc. provides secure mobile messaging services. It offers secure, real-time mobile messaging for the enterprise, empowering organizations to work more securely. The company serves healthcare, enterprise, personal and developers. The company was founded by Jeffrey Albert Evans, Andrew A. Brooks and Brad Brooks in 2010 and is headquartered in Santa Monica, CA.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA.

zeotap GmbH offers a solution for telecom operators. It provides a technology platform that transmits data securely and in a privacy-compliant way for businesses and consumers. The company was founded by Daniel Heer, Stephan Schwebe and Projjol Banerjea and is headquartered in Berlin, Germany.

Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom.

Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom.

Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands.

Montblanc India Retail Pvt Ltd. engages in trading of goods. The company is headquartered in Bangalore, India.

NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.

Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom.

Pakal Technologies, Inc. provides and designs next generation of IGTO power devices. The company is headquartered in San Francisco, CA.

ChromaCure SA develops therapeutic molecules to fight against cancer. The company is based in Charleroi, Belgium. The Belgian company was founded in 2018 by Cedric Blanpain, who has been the CEO since 2018.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.